For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Mometasone Furoate 80 ug Daily Via the Concept1 Device | Mometasone furoate (MF) delivered via Concept1, 80 μg daily in the evening | None | None | 0 | 186 | 13 | 186 | View |
| Mometasone Furoate 200 ug Daily Via the Twisthaler® Device | Mometasone furoate delivered via Twisthaler®, 200 μg daily in the evening | None | None | 0 | 180 | 17 | 180 | View |
| Mometasone Furoate 320 ug Daily Via the Concept1 Device | Mometasone furoate (MF) delivered via Concept1, 320 μg daily in the evening | None | None | 1 | 183 | 15 | 183 | View |
| Mometasone Furoate 800 ug Via the Twisthaler® Device | Mometasone furoate delivered via Twisthaler®, 800 μg daily in the evening | None | None | 0 | 186 | 8 | 186 | View |
| Total | Total | None | None | 1 | 735 | 53 | 735 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Nasopharyngitis | SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA 16.1 | View |
| Blood cortisol decreased | SYSTEMATIC_ASSESSMENT | Investigations | MedDRA 16.1 | View |
| Headache | SYSTEMATIC_ASSESSMENT | Nervous system disorders | MedDRA 16.1 | View |
| Oropharyngeal pain | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | MedDRA 16.1 | View |